Controversial PrEP Drug with Less Potential Side Effects Coming Soon
A new drug to prevent HIV could hit markets very soon. The results of the world’s biggest ever HIV prevention studies revealed the drug, Descovy, was as good as Truvada when it came to preventing HIV. Truvada and generic versions of it are used around the world as pre-exposure prophylaxis (PrEP). For two years, pharmaceutical giant Gilead has conducted the DISCOVER trial. The trial measured the efficacy of Descovy as a potential new PrEP drug. The study conducted across 50 sites in the United States, enrolled 5,387 cis men who have sex with men (MSM) and trans women at risk […]